Similar Search Results

Scherer, Frederic M. - 2014

challenges encountered in the discovery and development of superior new pharmaceuticals. The changing methods by which drugs are …

Persistent link: https://www.econbiz.de/10014058289

Incentives for pharmaceutical innovation : what's working, what's lacking

Kyle, Margaret K. - In: International journal of industrial organization 84 (2022), pp. 1-13

Persistent link: https://www.econbiz.de/10013435532

Changing innovation in the pharmaceutical industry : globalization and new ways of drug development ; with 28 tables

Jungmittag, Andre (ed.); Reger, Guido (contributor); … - 2000

Persistent link: https://www.econbiz.de/10001480694

Globale Pharmaindustrie - quo vadis? : Daten, Hintergründe und Analysen - eine Branchenbewertung

Watzek, Georg - 2022 - 2., aktualisierte und ergänzte Auflage

Persistent link: https://www.econbiz.de/10012669090

Globale Pharmaindustrie - quo vadis? : Daten, Hintergründe und Analysen - eine Branchenbewertung

Watzek, Georg - 2022 - 2., aktualisierte und ergänzte Auflage

-- Wirtschaftliche Analyse der Pharmaindustrie -- Ökonomische Randbereiche der Pharmabranche -- Derzeitiger Stand der … Pharmaindustrie -- Resümee. …

Persistent link: https://www.econbiz.de/10013192327

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...